Paracetamol raises blood pressure study
Analysis based on 7 articles · First reported Sep 01, 2026 · Last updated Sep 07, 2026
The study may influence prescribing practices for paracetamol, potentially reducing long-term use among hypertension patients and shifting some demand to alternative pain management. Pharmaceutical companies that market paracetamol could face reputational and sales pressure, while healthcare systems may see changes in chronic pain treatment protocols.
A University of Edinburgh study, published in the scientific journal Circulation, found that regular use of paracetamol increases blood pressure in patients with hypertension. The randomized clinical trial involved 110 patients with a history of high blood pressure who were prescribed one gram of paracetamol four times a day or a placebo for two weeks. Those taking paracetamol saw a significant increase in blood pressure compared to placebo, an effect similar to that of NSAIDs and potentially increasing the risk of heart disease or stroke by about 20%. The findings challenge the long-held view that paracetamol is a safer painkiller for people with high blood pressure. Experts, including Professor Jim Dear and Dr Iain Macintyre, emphasized that short-term use is fine but regular long-term use carries risks. The British Heart Foundation funded the study, and its medical director, Professor Sir Nilesh Samani, called for regular reviews of long-term prescriptions. Blood Pressure UK's CEO Phil Pyatt also warned about the hidden sodium in soluble paracetamol. The study suggests that patients and doctors should weigh risks and benefits, and consider lower doses or alternatives for chronic pain management.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard